Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(1.44)
# 1747
Out of 5,218 analysts
38
Total ratings
66.67%
Success rate
12.48%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BioNTech | Maintains: Strong Buy | 95 150 | 120.2 | 24.79% | 9 | Sep 19, 2024 | |
Moderna | Upgrades: Hold | 85 80 | 41.83 | 91.25% | 8 | Aug 6, 2024 | |
Grifols | Downgrades: Sell | n/a | n/a | n/a | 2 | Mar 12, 2024 | |
AstraZeneca | Downgrades: Hold | n/a | n/a | n/a | 3 | Feb 8, 2024 | |
Alvotech | Maintains: Hold | 8 12 | 11.8 | 1.69% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | n/a | n/a | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 4 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 35 | 3.15 | 1011.11% | 1 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | n/a | n/a | n/a | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | n/a | n/a | n/a | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 1 | Jul 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | n/a | n/a | n/a | 2 | Feb 4, 2021 |